I-aspirin ingenye yemithi esetshenziswa kakhulu emhlabeni , futhi abantu abaningi bayazibuza ukuthi ukuyithatha nsuku zonke kungabasiza yini baphile isikhathi eside futhi kangcono, ikakhulukazi ukuvimbela ukuhlaselwa yinhliziyo, isifo sohlangothi, noma ezinye izinhlobo zomdlavuza. Kodwa-ke, uma kukhulunywa ngokuyithatha nsuku zonke, izinto ziba nzima: akuyona nje umuthi olula wokuqeda ubuhlungu bekhanda, kodwa umuthi onemiphumela enamandla egazini nasesimisweni senhliziyo nemithambo yegazi.
Eminyakeni yamuva nje, izifundo eziningana ezinkulu ziye zawungabaza umqondo wokuthi noma ubani angazuza nge-aspirin yansuku zonke njengendlela yokuvimbela . Ikakhulukazi, kuye kwabonakala ukuthi kubantu abadala abanempilo, lo mkhuba ungase ungabi nezinzuzo ezicacile futhi, esikhundleni salokho, ungandisa ingozi yokopha kanye nezinhlobo ezithile zomdlavuza othuthukile. Ngakho-ke, manje kunanini ngaphambili, kubalulekile ukuqonda ngokugcwele izingozi nezinzuzo ngaphambi kokwenza noma yiziphi izinqumo wedwa.
Yini ngempela eyenziwa yi-aspirin emzimbeni?
I-aspirin ingeyeqembu lemithi engeyona eye-steroidal anti-inflammatory (NSAIDs) futhi, ngemithamo ephezulu, isetshenziswa njengesidambisi-zinhlungu kanye nesiqeda ubuhlungu nomkhuhlane. Kodwa-ke, ngemithamo ephansi (ngokuvamile engu-75-100 mg ngosuku) isetshenziswa ngesizathu esihlukile: ivimbela ama-platelet ukuthi ahlangane futhi akhe amahlule egazi kalula.
Lawa mahlule, noma i-thrombi, angavimba imithambo ebalulekile yenhliziyo : uma eyodwa yakheka emthanjeni wenhliziyo futhi ivimbele ukugeleza kwegazi, kwenzeka i-myocardial infarction (ukuhlaselwa yinhliziyo); uma ivimba umthambo othwala igazi liye ebuchosheni, kungavela isifo sohlangothi esingena emzimbeni. Ngokwenza igazi lingathambekeli kakhulu ekwakheni i-thrombi, futhi uma ubheka ukuthi izitshalo ezifana ne -ginkgo biloba nazo zithinta ukujiya kwegazi, i-aspirin ephansi isetshenziswe amashumi eminyaka ukunciphisa ingozi yokuhlaselwa yinhliziyo kanye nokujiya kwegazi kubantu abasengozini enkulu.
Le ndlela elula yokusebenza, kuhlanganiswe neqiniso lokuthi iyisidakamizwa esingabizi futhi esaziwa kabanzi, ikhuthaze umbono wokuthi ukusithatha nsuku zonke kungaba uhlobo "lomshwalense" wokuhlaselwa yinhliziyo nezinye izinkinga ezinkulu . Kusukela lapho kwavela intshisekelo yokufunda ukuthi ngabe kungathinta yini nezinye izifo, njengezinhlobo ezithile zomdlavuza, ikakhulukazi umdlavuza we-colorectal.
Kubalulekile ukukhumbula ukuthi, naphezu kodumo lwayo "njengoluphephile," i-aspirin ayiyona ingozi: ngokuphazamisa ukujiya kwegazi, yandisa ingozi yokopha , ikakhulukazi endleleni yokugaya ukudla, lapho i-Helicobacter pylori ingandisa khona ingozi, futhi, ngezinga elincane, ebuchosheni. Ngakho-ke, noma yisiphi isinqumo sokuyithatha isikhathi eside sihlala sihilela ukulinganisa ikhono layo lokuvimbela ukujiya kwegazi ngokumelene nengozi yokubangela ukopha.
I-aspirin nomdlavuza: okwakwaziwa ngaphambili
Sekungamashumi eminyaka, izifundo zokuhlola ziqongelelene zibonisa ukuthi abantu abavame ukuthatha i-aspirin babonakala benokuxilongwa okuncane komdlavuza kanye namazinga aphansi okufa ngenxa yomdlavuza, ikakhulukazi umdlavuza wamathumbu amakhulu kanye nomdlavuza wamathumbu. Lezi zifundo zazingezona izivivinyo zokuhlola, kodwa zazihlaziya izizindalwazi ezinkulu zeziguli esezivele zithatha i-aspirin ngezinye izizathu.
Eziningi zalezi zifundo zithole ukwehla okukhulu kwengozi yomdlavuza we-colonectal kulabo abawusebenzisa isikhathi eside. Kwabonakala nama-polyp ambalwa ngaphambi komdlavuza emathunjini, okuphakamisa ukuthi i-aspirin ingathonya ukukhula kwesimila kusukela ezigabeni zokuqala, mhlawumbe ngezindlela zokulwa nokuvuvukala noma ngokushintsha impendulo yomzimba kumaseli angajwayelekile.
Icala elaziwa kakhulu ngelabantu abane- Lynch syndrome , isifo esizuzwe njengefa esikhuphula kakhulu ingozi yomdlavuza wamathumbu amakhulu kanye nezinye izimila zokugaya ukudla. Kuleli qembu, ukuhlolwa kwezokwelapha nge-aspirin eningi (600 mg nsuku zonke okungenani iminyaka emibili) kubonise ukwehla okungaphezu kwengxenye eyodwa kwezintathu kwezehlakalo zomdlavuza wamathumbu amakhulu . Lobu bufakazi babunamandla kangangokuthi izinqubo ze-aspirin manje zamukelwa njengesu lokuvimbela iziguli ezinalesi sifo, njalo ngaphansi kokubhekwa okuqinile kwezokwelapha.
Ngokuhamba kwesikhathi, nangokuhlanganisa imiphumela yezifundo ezahlukene, kwaphakanyiswa ukuthi i-aspirin ingase ingagcini nje ngokunciphisa ukuvela kwama-polyps nama-tumors , kodwa futhi ithuthukise amazinga okusinda kwezinye izinhlobo zomdlavuza wokugaya ukudla. Kodwa-ke, eziningi zalezi zivivinyo azizange zaklanywe kusukela ekuqaleni ngomdlavuza njengenhloso eyinhloko; kunalokho, lolo lwazi lwatholakala ngokwesibili, okuphakamisa imibuzo ethile yendlela yokusebenza.
Ukuhlanganiswa okusobala kwezinzuzo zenhliziyo kanye nokuvikelwa okungenzeka kumdlavuza we-colon kwakuthakazelisa kangangokuthi, ngo-2016, i-United States Preventive Services Commission (USPSTF) yancoma ukusetshenziswa kwe-aspirin nsuku zonke ngamanani aphansi emaqenjini athile abantu abasengozini enkulu yenhliziyo, futhi ihlola amandla ayo okunciphisa ingozi yomdlavuza we-colon.
Ucwaningo lwe-ASPREE: lapho imiphumela iphendula umbhalo ekhanda lawo
Kulesi simo esithandwa kakhulu yi-aspirin, ucwaningo lwe-ASPREE (i-Aspirin ekuncishisweni kwezehlakalo kubantu abadala) lwashaqisa ngempela. Kwakuyisilingo somtholampilo esingahleliwe—uhlobo locwaningo olunobufakazi obuphezulu kakhulu—olwaklanyelwe ukuhlaziya ukuthi i-aspirin ephansi ihlinzeka yini ngezinzuzo kubantu abadala abanempilo.
I-ASPREE yayihlanganisa ababambiqhaza ababalelwa ku-19.000 abaneminyaka engu-70 nangaphezulu (abancane kancane emaqenjini athile athile), ngokuvamile abanempilo enhle, abangenayo i-dementia noma ukukhubazeka okukhulu ngokomzimba ekuqaleni. Iningi labo lalingazange lithathe i-aspirin njalo ngaphambi kocwaningo. Babelwa ngokungahleliwe ukuthola i-aspirin engu-100 mg nsuku zonke noma i-placebo , futhi balandelwa cishe iminyaka emihlanu.
Ukugxila okuyinhloko kwalolu cwaningo kwakungewona umdlavuza, kodwa kunalokho ukuthi ngabe i-aspirin isize yini ekunciphiseni ukwanda kwesifo sokuwohloka komqondo, ukukhubazeka ngokomzimba okungapheli, noma ukufa ngenxa yanoma yisiphi isizathu . Umphumela engozini yomdlavuza kanye nokufa okuhlobene nomdlavuza ubhalwe njengomgomo wesibili, kodwa wawusaqoqwa futhi wahlaziywa ngokucophelela.
Imiphumela yokuqala eshicilelwe kakade yembule okuthile okukhathazayo: iqembu elathola i-aspirin landa kancane ekufeni okuphelele uma kuqhathaniswa neqembu le-placebo. Ukuhlaziywa komthombo walo mehluko kubonise ukuthi kwakubangelwa kakhulu inani eliphezulu lokufa komdlavuza phakathi kwalabo abathatha imithi nsuku zonke.
Lapho ithimba lihlola le datha yomdlavuza ngokuningiliziwe, alitholanga ukwanda okucacile kwenani eliphelele lokuxilongwa komdlavuza eqenjini le-aspirin uma kuqhathaniswa neqembu le-placebo. Kodwa-ke, babone ukwanda okungaba ngu-20% engcupheni yokutholakala nomdlavuza othuthukile (okungukuthi, ngokusabalala kwesifo noma ezinye izindlela zokuthola isifo esisakazekile) kanye nokwanda cishe okungu-30% kwamathuba okufa ngenxa yomdlavuza othuthukile.
Lokhu okutholakele kwakumangalisa kakhulu endabeni yomdlavuza we-colorectal , kanye nesimila okwakukhuthazwa kakhulu indima yokuvikela ye-aspirin. Ku-ASPREE, ingozi yokufa ngenxa yomdlavuza wamathumbu amakhulu kanye nomdlavuza wamathumbu eqenjini elithatha i-aspirin yayiphakeme cishe ngo- 77% kunaseqenjini le-placebo. Ochwepheshe abaningana bachaze le miphumela "njengengalindelekile nhlobo" futhi bagcizelela isidingo sophenyo olwengeziwe mayelana nokuthi kungani lokhu kungenzeka kubantu abadala.
Ukuguga njengento ebalulekile emiphumeleni ye-aspirin
Omunye wemibuzo emikhulu abacwaningi abayihlolayo ocwaningweni lwe-ASPREE ukuthi ngabe ubudala buyayishintsha kakhulu yini indlela umzimba osabela ngayo ku-aspirin . Izifundo eziningi ezithole izinzuzo zokulwa nomdlavuza zihlanganise kakhulu abantu abadala abaseminyakeni ephakathi noma abasebasha, kanti i-ASPREE igxile kubantu abanempilo abaneminyaka engaphezu kuka-70.
Ebudaleni, umzimba awusebenzi ngendlela efanayo naleyo owawusebenza ngayo eminyakeni yawo-40 noma 50: isimiso somzimba sokuzivikela sivame ukuba buthakathaka futhi sisabela ngendlela ehlukile ezifweni, ekuvuvukeni, kanye namangqamuzana esimila . Kuye kwaphakanyiswa ukuthi i-aspirin ingaphazamisa izindlela ezithile zomzimba ezisiza ekugcineni izimila ezikhona kodwa ezisafihliwe zilawulwa, zivumele ukuba zibalekele ukulawula futhi zithuthukele ezigabeni eziphambili.
Abalobi bocwaningo kanye nabanye ochwepheshe basikisela ukuthi i-aspirin ingaba nemiphumela ephambene kuye ngesigaba sokuphila . Ingaba nendima yokuvikela kakhulu uma iqalwa eminyakeni ephakathi futhi iqhubeke iminyaka eminingi, kanti ukuyiqala okokuqala ngemva kweminyaka engu-70 kubantu ababonakala bephilile kungenza ibhalansi ibe sengozini enkulu yomdlavuza othuthukile kanye nokopha okukhulu.
Ukuze kuqhutshekwe nokuphenya ngalo mbono, ithimba le-ASPREE ligcine amasampula egazi nezicubu zesimila ezivela kubahlanganyeli, ngenhloso yokufunda izimpawu zomzimba kanye nama-molecule ezizosiza ukuqonda kangcono ukuthi i-aspirin ithonya kanjani intuthuko kanye nokuqhubeka kwezimila kubantu abadala. Bahlela futhi ukuqhubeka nokuqapha ababambiqhaza iminyaka eminingana eyengeziwe, njengoba kwezinye izifundo, izinzuzo ezingaba khona ngokumelene nomdlavuza azizange zibonwe kwaze kwaba yiminyaka eyishumi ngemuva kokuqala ukwelashwa.
Ochwepheshe abaningana bokuvimbela umdlavuza bagcizelela ukuthi isifundo esibalulekile se-ASPREE ukuthi lokho okusebenza ku-50 akukwazi ukucatshangwa ukuthi kusebenza ngendlela efanayo ku-75. Ngamazwi abanye abacwaningi, kusobala ukuthi kukhona okuhlukile ngebhayoloji yomdlavuza ekugugeni noma endleleni abantu abadala abasabela ngayo emithini yokuvimbela. Lokhu kuqinisa umqondo wokuthi ukuvimbela kumele kube yinto yomuntu siqu kakhulu.
Izinzuzo zenhliziyo nemithambo yegazi ze-aspirin yansuku zonke
Ngaphandle komdlavuza, isizathu esiyinhloko sokuthi odokotela abaningi banikeze i-aspirin nsuku zonke yikhono layo lokunciphisa izehlakalo zenhliziyo ezifana nokuhlaselwa yinhliziyo noma isifo sohlangothi . Kubalulekile ukuhlukanisa phakathi kwezimo ezimbili ezihluke kakhulu: ukuvimbela okuyinhloko (ukuvimbela isehlakalo sokuqala) kanye nokuvimbela okwesibili (ukuvimbela ukubuyela emuva komdlavuza kumuntu osevele enaso).
Emkhakheni wokuvimbela okwesibili , ubufakazi buyathandeka. Uma usuvele uhlaselwe yinhliziyo, isifo sohlangothi esibangelwa yi-ischemic, noma izinkinga ezithile zemithambo yegazi, ukuthatha umthamo ophansi we-aspirin nsuku zonke kuvame ukuba yisibonakaliso esicacile , ngaphandle kwezimo ezithile ezingahambisani nokusetshenziswa. Kulezi zimo, ingozi yokwakheka kwamahlule egazi amasha iphezulu, futhi izinzuzo ze-aspirin zidlula kakhulu izingozi zokopha ezigulini eziningi.
Kodwa-ke, ekuvimbeleni okuyinhloko —okungukuthi, kubantu abangakaze babe nokuhlaselwa yinhliziyo noma isifo sohlangothi—isimo asicaci kangako. Kwabanye abantu abadala abaneminyaka ephakathi kuka-40 no-59 ubudala abanengozi ephezulu yesifo senhliziyo (ngenxa yezici ezifana nomfutho wegazi ophakeme, i-cholesterol ephezulu, ukubhema, noma isifo sikashukela), umthamo ophansi we-aspirin unganciphisa kancane amathuba okuba kwenzeke okokuqala . Noma kunjalo, le nzuzo engaba khona kumele ilinganiswe nengozi eyengeziwe yokopha, ikakhulukazi esiswini, emathunjini, noma ebuchosheni.
Isibonelo esichazayo yisifundo se -ASCEND , esenziwa kubantu abanesifo sikashukela, iqembu elinamathuba amaningi okuhlushwa yizinkinga zenhliziyo nemithambo yegazi. Lolu cwaningo lubonise ukuthi, yize i-aspirin inciphise izehlakalo zenhliziyo ngezinga elithile, yandisa kakhulu ingozi yokopha kwamathumbu . Lapho ilinganiswa, inzuzo eningi yayincane kakhulu, okwaholela ekuqapheleni okukhulu ekuyincomeni njalo kubo bonke abanesifo sikashukela sohlobo 2.
Ngakho-ke, emikhubeni yezokwelapha yamanje, izincomo ziya endleleni ekhetha kakhulu: akukhuthazwa ukuthi wonke umuntu ophilile athathe i-aspirin nsuku zonke "uma kwenzeka ." Kunalokho, icala ngalinye lihlolwa ngokwalo, kubalwa ingozi elinganisiwe yesifo senhliziyo kanye nengozi yomuntu ngamunye yokopha, ukuze kunqunywe ukuthi ukwethula umuthi kuyazuzisa yini noma cha.
Izingozi ezinkulu zokuthatha i-aspirin nsuku zonke
Intengo eyinhloko okufanele ikhokhwe ngemiphumela ye-aspirin yokulwa nokuvuvukala kwegazi ingozi eyengeziwe yokopha , engashintshwa kakhulu ngezinye izinto ezifana netiye eliluhlaza . Lo mphumela omubi awubalulekile futhi uba yinkinga kakhulu ngemithamo ephezulu futhi umuntu owuthathayo ukhula.
Inkinga evame kakhulu ukopha kwamathumbu , okungabonakala njengokuphuma kwegazi esiswini noma emathunjini. Kulezi zimo, ukulungisa ukudla ukuze kulwiwe ne-gastritis kungasiza ekunciphiseni umonakalo. Ngezinye izikhathi kubonakala njengendle emnyama noma enegazi, ukuhlanza igazi, noma i-anemia eqhubekayo ngaphandle kwezinye izimpawu ezibonakalayo. Ezimweni ezimbi kakhulu, lokhu kukopha kungaba yingozi empilweni futhi kudinga ukulaliswa esibhedlela, ukumpontshelwa igazi, noma ukuhlinzwa okuphuthumayo.
Enye ingozi, engavamile kodwa eyesatshwa kakhulu, ukuphuma kwegazi ngaphakathi kobuchopho , okungukuthi, ukuphuma kwegazi ngaphakathi kogebhezi. Nakuba amathuba aphelele ephansi, umphumela ungaba mubi kakhulu. Le ngozi iyanda ngokuguga, kubantu abanomfutho wegazi ophakeme ongalawulwa kahle, noma kulabo abake baba nokuphuma kwegazi ebuchosheni ngaphambilini.
Ngaphezu kokopha, kuneminye imiphumela emibi kanye nokuphikisana . Abantu abanezilonda zesisu noma ze-duodenal ezisebenzayo, umlando wokopha okukhulu kwesisu, noma izinkinga ezinkulu zokujiya kwegazi ngokuvamile abafanelekeli i-aspirin yansuku zonke, ngaphandle kokuthi ithathwe nezivikeli zesisu futhi inzuzo elindelekile iphezulu kakhulu. Lokhu kusebenza nakulabo abangabekezeleli noma abangazweli kuma-NSAID, noma izinhlobo ezithile ze-asthma ezibangelwa yile mithi.
Kubalulekile ukugcizelela ukuthi ingozi yezinkinga zokopha iyanda ngokuguga . Ngakho-ke, kubantu abadala, ikakhulukazi labo abangenawo umlando wokuhlaselwa yinhliziyo noma isifo sohlangothi, ibhalansi phakathi kwezinzuzo nezingozi iyanda ngokuya iqapha. Ochwepheshe abaningi bayavuma ukuthi, ngaphandle kwesibonakaliso esicacile, ukuqala i-aspirin nsuku zonke kubantu abadala kuphela njengendlela yokuvimbela "ejwayelekile" akufanelekile.
I-aspirin yansuku zonke inganikezwa nini futhi nini?
Njengoba ucabanga ngalo lonke lolu lwazi, isincomo esinengqondo kakhulu ukuthi ungalokothi uqale ukuthatha i-aspirin nsuku zonke ngaphandle kokubonisana nochwepheshe wezempilo . Isinqumo kufanele senziwe ngabanye futhi sisekelwe ezicini ezithile zobungozi zomuntu ngamunye.
Kunezimo lapho ukuphuza i-aspirin nsuku zonke ngokuvamile kuvunyelwe khona, uma nje kungekho ziphazamiso: ukube uke wahlaselwa yinhliziyo ngaphambilini, washaywa yisifo sohlangothi, noma izifo ezithile zenhliziyo noma zemithambo yegazi . Kulezi zimo, iziqondiso zokwelapha zisekela kakhulu ukusetshenziswa kwayo okuqhubekayo ngemithamo ephansi (isibonelo, i-100 mg ngosuku), ngaphandle kokuthi udokotela unquma ngenye indlela ngezizathu ezithile.
Kwamanye amaqembu, njengeziguli ezinesifo sikashukela sohlobo 2 ezingenaso isenzakalo senhliziyo ngaphambili, kusalokhu kungqubuzana. Ezinye izifundo ziphakamisa inzuzo encane ekunciphiseni ukuhlaselwa yinhliziyo nezinye izinkinga zenhliziyo, kodwa ingozi yokopha inganciphisa kancane lo mphumela omuhle . Kukhona ngisho nezifundo ezihlole izindlela zokwelashwa ngamaphilisi amabili angu-100 mg nsuku zonke emaqenjini athile amancane, kodwa lawa maqhinga kumele ahlolwe ngokucophelela okukhulu.
Ukusetshenziswa kwe-aspirin kuye kwacatshangelwa nakubantu abaye baba nomdlavuza wesimiso sokugaya ukudla (njenge-colon noma i-rectum). Olunye ulwazi lubonisa ukuthi lungasiza ekunciphiseni amathuba okusabalala noma ukuphinda kuvele isifo, ikakhulukazi ezimilaneni ezinezici ezithile zofuzo. Kodwa-ke, lezi yizinqumo eziqondile kakhulu ezenziwa ezindaweni zomdlavuza, ngemva kokuhlola ngokucophelela iphrofayili yengozi yesiguli ngasinye kanye nomlando womndeni.
Ngakolunye uhlangothi, i-aspirin yansuku zonke ivame ukugwenywa, ngaphandle kwezimo ezithile zezokwelapha, kulabo abaye bahlushwa izilonda ezinzima, ukopha kwamathumbu, ukungagayi kahle kokudla , noma labo asebevele bedinga ezinye izidakamizwa zokulwa nokugaya igazi ezinamandla kakhulu (njenge-acenocoumarol noma izidakamizwa zomlomo zesizukulwane esisha) ukwelapha i-arrhythmias njenge-atrial fibrillation. Kulezi zimo, ukwengeza i-aspirin kungandisa kakhulu ingozi yokopha ngaphandle kokunikeza inzuzo elinganayo, kanti ezinye izithako ezifana negalikhi kanye ne-contraindications yazo zingandisa kakhulu le ngozi.
Njengomthetho ojwayelekile, uma udokotela wakho ekuyalela ukuthi kusetshenziswe nsuku zonke, ngokuvamile bazoncoma ukuthi kuthathwe ngemva kokudla, hhayi esiswini esingenalutho , ukuze kuncishiswe ukungakhululeki kokugaya ukudla. Kodwa-ke, umthamo othize kanye nokufaneleka kokusebenzisa izivikeli zesisu kufanele kunqunywe njalo nguchwepheshe wezempilo.
Ngakho konke esikwaziyo kuze kube manje, kubonakala kusobala ukuthi i-aspirin isishintshe ekubeni “iphilisi eliyisimangaliso” yaya ekubeni iqondwe njengomuthi onamandla ongaba usizo kakhulu kwabanye abantu futhi ongafaneleki kwabanye . Umyalezo oyinhloko ukugwema ukuzelapha isikhathi eside futhi uhlale ufuna ukuhlolwa komuntu ngamunye kwezingozi zenhliziyo, umdlavuza kanye nokopha.
Ekugcineni, ubufakazi obusha, okuhlanganisa nezifundo ezifana ne-ASPREE ne-ASCEND, buholela ochwepheshe abaningi ukuba bacabange kabusha ngokusetshenziswa kwe-aspirin ngokungakhethi kubantu abaningi njengendlela yokuvimbela . Umkhuba wamanje uwukugcinela labo abangazuza kakhulu emiphumeleni yayo kunokuba babhekane nezinkinga zayo ezingaba khona, kuyilapho ucwaningo luqhubeka nokucacisa ukuthi yiziphi izinkomba zeziguli ezizuzayo ngempela nokuthi yiziphi izigaba zokuphila ezifanele kakhulu ukuyisebenzisa.
Konke kusikisela ukuthi ikusasa le-aspirin yokuvimbela lizoba ngelomuntu siqu futhi likhetheke kakhulu , kucatshangelwa hhayi ubudala kuphela, kodwa nomlando womndeni, izakhi zofuzo, isimo sesimiso somzimba sokuzivikela, kanye nokuba khona kwezinye izifo. Okwamanje, ngaphambi kokwenza i-aspirin ibe yinto evamile yansuku zonke, kufanelekile ukuhlala phansi nodokotela wakho, nibukeze ngokuthula izinzuzo nezingozi, futhi ninqume ndawonye ukuthi, esimweni sakho esithile, iyazuzisa ngempela yini.
